1. Home
  2. AQST vs BYND Comparison

AQST vs BYND Comparison

Compare AQST & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • BYND
  • Stock Information
  • Founded
  • AQST 2004
  • BYND 2009
  • Country
  • AQST United States
  • BYND United States
  • Employees
  • AQST N/A
  • BYND N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • BYND Packaged Foods
  • Sector
  • AQST Health Care
  • BYND Consumer Staples
  • Exchange
  • AQST Nasdaq
  • BYND Nasdaq
  • Market Cap
  • AQST 272.9M
  • BYND 258.5M
  • IPO Year
  • AQST 2018
  • BYND 2019
  • Fundamental
  • Price
  • AQST $4.06
  • BYND $3.46
  • Analyst Decision
  • AQST Strong Buy
  • BYND Sell
  • Analyst Count
  • AQST 7
  • BYND 3
  • Target Price
  • AQST $11.29
  • BYND $4.00
  • AVG Volume (30 Days)
  • AQST 1.3M
  • BYND 1.6M
  • Earning Date
  • AQST 08-05-2025
  • BYND 08-06-2025
  • Dividend Yield
  • AQST N/A
  • BYND N/A
  • EPS Growth
  • AQST N/A
  • BYND N/A
  • EPS
  • AQST N/A
  • BYND N/A
  • Revenue
  • AQST $54,228,000.00
  • BYND $319,580,000.00
  • Revenue This Year
  • AQST N/A
  • BYND N/A
  • Revenue Next Year
  • AQST $45.71
  • BYND $3.36
  • P/E Ratio
  • AQST N/A
  • BYND N/A
  • Revenue Growth
  • AQST 5.29
  • BYND N/A
  • 52 Week Low
  • AQST $2.12
  • BYND $2.23
  • 52 Week High
  • AQST $5.80
  • BYND $9.24
  • Technical
  • Relative Strength Index (RSI)
  • AQST 72.86
  • BYND 54.68
  • Support Level
  • AQST $3.62
  • BYND $3.45
  • Resistance Level
  • AQST $3.80
  • BYND $3.62
  • Average True Range (ATR)
  • AQST 0.19
  • BYND 0.14
  • MACD
  • AQST 0.05
  • BYND -0.02
  • Stochastic Oscillator
  • AQST 95.43
  • BYND 46.15

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: